MYSM1 and prostate cancer: Early studies have linked H2A deubiquitination to prostate cancer where MYSM1 regulated androgen receptor-dependent gene activation by coordinating histone acetylation and deubiquitination, and destabilizing the association of linker histone H1 with nucleosomes [9].